Related Experiment Video
Updated: May 5, 2026
10:27
Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
25.0K
Decoding the immunophenotype ‒ New perspectives in understanding celiac disease
Carlota García-Hoz1, Roberto Pariente1, Garbiñe Roy Ariño2
1Inmunología, Hospital Universitario Ramón y Cajal. Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS).
Revista Espanola De Enfermedades Digestivas
|November 17, 2025
Summary
Flow cytometry of duodenal intraepithelial lymphocytes (IELs) accurately identifies celiac disease. This
Area of Science:
- Immunology
- Gastroenterology
- Cell Biology
Background:
- Increased duodenal intraepithelial lymphocytes (IELs) are hallmarks of celiac enteropathy.
- Accurate diagnosis relies on characterizing IEL subpopulations.
Purpose of the Study:
- To highlight the clinical implementation of the duodenal IEL lymphogram technique.
- To standardize interpretation of IEL analysis parameters.
Main Methods:
- Utilizing flow cytometry for duodenal intraepithelial lymphocyte (IEL) analysis.
- Establishing the 'duodenal IEL lymphogram' for phenotype and distribution assessment.
Main Results:
- The duodenal IEL lymphogram offers high diagnostic accuracy for celiac disease.
- Specific IEL phenotypes and distributions are pathognomonic for celiac processes.
Conclusions:
- The duodenal IEL lymphogram is a valuable diagnostic tool for celiac disease.
- Harmonization of laboratory interpretation is crucial for consistent results.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
129
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
129
01:26Inflammatory Bowel Disease I: Introduction
79
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows...
79
01:25Inflammatory Bowel Disease III: Crohn's Disease
69
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
69